Cell Therapy Manufacturing Market - Global
Industry Insights, Trends, Outlook and Opportunity
Analysis, 2018-2026
Cell therapy is one of the most promising healthcare procedure for restoration of damaged
tissue. Cell therapies have huge potential for the wide range of disease treatment including
tissue degradation, immune deficiency, metabolic disorders, and cancer. Cell therapy are
categorized into two type’s allogeneic (cells from third party donor) and autologous (cells from
one’s own body). Cell therapy has gained significant traction in recent past and currently it
under commercial development. Main objective of cell therapy is to re-establish the lost
function of tissues and cells rather than to produce a new organ. Some cell therapies have been
established and permitted for clinical trial. For instance, in 2013 a stage 2 clinical trial was
completed for transplantation of bone marrow derived stem cells in affected knee by rheumatoid
arthritis. The growth of this technique is also increased due to involvement of the government
agencies. For instance, innovate U.K. 2014 report showed that government agreed to fund
US$15.3 million in cell therapy manufacturing market.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/1728
Cell Therapy Manufacturing Market Dynamics
Increasing number of surgical procedures performed across the world coupled with increasing
number of trauma and accidents is propelling demand for new medical therapy. For instance,
according to a 2015, World Health Organization (WHO) report, more than 50,000 stem cell
transplants are carried out annually worldwide for various surgeries. Stem cells transplantation
is promising medical therapy for patients with advance stage diseases like Alzheimer’s, arthritis,
autism, blindness, cancer, cerebral palsy, diabetes etc. Key biopharmaceutical companies are
majorly investing in research for cell therapy. For instance, Longeveron LL, a biopharmaceutical
company received a US$ 750,000 grant from the Maryland Technology Development Corporation
(TEDCO) in 2018 for stem cell therapy research. These collaborations and government funding
are boosting growth of the cell therapy manufacturing market. However, the strict regulations,